Advertisement
Review Article|Articles in Press

Allergic Rhinitis

  • Eric J. Czech
    Correspondence
    Corresponding author.
    Affiliations
    Division of Physician Assistant Studies, Department of Family Medicine, The University of Toledo College of Medicine and Life Sciences, 3333 Glendale Avenue, Toledo, OH 43614, USA

    Department of Family Medicine, The University of Toledo College of Medicine and Life Sciences, 3333 Glendale Avenue, Toledo, OH 43614, USA
    Search for articles by this author
  • Andrew Overholser
    Affiliations
    Division of Physician Assistant Studies, Department of Family Medicine, The University of Toledo College of Medicine and Life Sciences, 3333 Glendale Avenue, Toledo, OH 43614, USA

    Department of Family Medicine, The University of Toledo College of Medicine and Life Sciences, 3333 Glendale Avenue, Toledo, OH 43614, USA
    Search for articles by this author
  • Paul Schultz
    Affiliations
    Department of Family Medicine, The University of Toledo College of Medicine and Life Sciences, 3333 Glendale Avenue, Toledo, OH 43614, USA
    Search for articles by this author
Published:March 08, 2023DOI:https://doi.org/10.1016/j.pop.2023.01.003

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Primary Care: Clinics in Office Practice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Mims J.W.
        Epidemiology of allergic rhinitis.
        Int Forum Allergy Rhinol. 2014; 4: S18-S20
        • Eifan A.O.
        • Durham S.R.
        Pathogenesis of rhinitis.
        Clin Exp Allergy. 2016; 46: 1139-1151
        • Ng M.L.S.
        • Warlow R.S.
        • Chrishanthan N.
        • et al.
        Preliminary criteria for the definition of allergic rhinitis: a systematic evaluation of clinical parameters in a disease cohort (I).
        Clin Exp Allergy. 2000; 30: 1314-1331
        • Bousquet J.
        • Khaltaev N.
        • Cruz A.A.
        • et al.
        Allergic rhinitis and its impact on asthma (ARIA) 2008∗.
        Allergy. 2008; 63: 8-160
        • Zhang Y.
        • Bielorya L.
        • Caia T.
        • et al.
        Predicting onset and duration of airborne allergenic pollen season in the United States.
        Atmos Environ. 1994; 103: 297-306
        • Koinis-Mitchell D.
        • Craig T.
        • Esteban C.A.
        • et al.
        Sleep and allergic disease: a summary of the literature and future directions for research.
        J Allergy Clin Immunol. 2012; 130: 1275-1281
        • Brawley A.
        • Silverman B.
        • Kearney S.
        • et al.
        Allergic rhinitis in children with attention-deficit/hyperactivity disorder.
        Ann Allergy Asthma Immunol. 2004; 92: 663-667
        • Acevedo-Prado A.
        • Seoane-Pillado T.
        • López-Silvarrey-Varela A.
        • et al.
        Association of rhinitis with asthma prevalence and severity.
        Sci Rep. 2022; 12https://doi.org/10.1038/s41598-022-10448-w
        • Hadley J.A.
        • Derebery M.J.
        • Marple B.F.
        Comorbidities and allergic rhinitis: Not just a runny nose.
        J Fam Pract. 2012; 61: S11-S15
        • Ryan D.
        How to identify and manage seasonal allergic rhinitis.
        J Community Nurs. 2016; 30: 54-59
        • Eren E.
        • Aktaş A.
        • Arslanoğlu S.
        • et al.
        Diagnosis of allergic rhinitis: inter-rater reliability and predictive value of nasal endoscopic examination: a prospective observational study.
        Clin Otolaryngol. 2013; 38: 481-486
        • Krzych-Fałta E.
        • Wojas O.
        • Samoliński B.K.
        • et al.
        Gold standard diagnostic algorithm for the differential diagnosis of local allergic rhinitis.
        Postepy Dermatol Alergol. 2022; 39: 20-25
        • Bridgeman M.B.
        Overcoming barriers to intranasal corticosteroid use in patients with uncontrolled allergic rhinitis.
        Integr Pharm Res Pract. 2017; 6: 109-119
        • Platts-Mills T.A.
        Allergen avoidance in the treatment of asthma and allergic rhinitis. Uptodate.com.
        2021 (Available at:) (Accessed September 27, 2022)
        • Tabatabaian F.
        • Casale T.B.
        Selection of patients for sublingual immunotherapy (SLIT) versus subcutaneous immunotherapy (SCIT).
        Allergy Asthma Proc. 2015; 36: 100-104
        • Nguyen S.A.
        • Psaltis A.J.
        • Schlosser R.J.
        Isotonic saline nasal irrigation is an effective adjunctive therapy to intranasal corticosteroid spray in allergic rhinitis.
        Am J Rhinol Allergy. 2014; 28: 308-311
        • Wallace D.V.
        • Dykewicz M.S.
        • Oppenheimer J.
        • et al.
        Pharmacologic treatment of seasonal allergic rhinitis: synopsis of guidance from the 2017 joint task force on practice parameters.
        Ann Intern Med. 2017; 167: 876-881
        • Small P.
        • Keith P.K.
        • Kim H.
        Allergic rhinitis.
        Allergy Asthma Clin Immunol. 2018; 14: 51
        • Fowler J.
        • Rotenberg B.W.
        • Sowerby L.J.
        The subtle nuances of intranasal corticosteroids.
        J Otolaryngol Head Neck Surg. 2021; 50: 18
        • Dykewicz M.S.
        • Wallace D.V.
        • Amrol D.J.
        • et al.
        Rhinitis 2020: a practice parameter update.
        J Allergy Clin Immunol. 2020; 146: 721-767
        • Juniper E.F.
        • Ståhl E.
        • Doty R.L.
        • et al.
        Clinical outcomes and adverse effect monitoring in allergic rhinitis.
        J Allergy Clin Immunol. 2005; 115: S390-S413
        • Schenkel E.J.
        • Skoner D.P.
        • Bronsky E.A.
        • et al.
        Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray.
        Pediatrics. 2000; 105: E22
        • Galant S.P.
        • Melamed I.R.
        • Nayak A.S.
        • et al.
        Lack of effect of fluticasone propionate aqueous nasal spray on the hypothalamic-pituitary-adrenal axis in 2- and 3-year-old patients.
        Pediatrics. 2003; 112: 96-100
        • Benninger M.S.
        • Ahmad N.
        • Marple B.F.
        The safety of intranasal steroids.
        J Otolaryngol Head Neck Surg. 2003; 129: 739-750
        • Wu E.L.
        • Harris W.C.
        • Babcock C.M.
        • et al.
        Epistaxis risk associated with intranasal corticosteroid sprays: a systematic review and meta-analysis.
        J Otolaryngol Head Neck Surg. 2019; 161: 18-27
        • Patel D.
        • Garadi R.
        • Brubaker M.
        • et al.
        Onset and duration of action of nasal sprays in seasonal allergic rhinitis patients: olopatadine hydrochloride versus mometasone furoate monohydrate.
        Allergy Asthma Proc. 2007; 28: 592-599
        • Loh C.Y.
        • Chao S.S.
        • Chan Y.H.
        • et al.
        A clinical survey on compliance in the treatment of rhinitis using nasal steroids.
        Allergy. 2004; 59: 1168-1172
        • Khattiyawittayakun L.
        • Seresirikachorn K.
        • Chitsuthipakorn W.
        • et al.
        Effects of decongestant addition to intranasal corticosteroid for chronic rhinitis: a systematic review and meta-analysis.
        Int Forum Allergy Rhinol. 2018; 8: 1445-1453
        • Wallace D.
        • Dykewicz M.
        • Bernstein D.
        • et al.
        The diagnosis and management of rhinitis: An updated practice parameter.
        J Allergy Clin Immunol. 2008; 122: S1-S84
        • Kaszuba S.M.
        • Baroody F.M.
        • deTineo M.
        • et al.
        Superiority of an intranasal corticosteroid compared with an oral antihistamine in the as-needed treatment of seasonal allergic rhinitis.
        Arch Intern Med. 2001; 161: 2581-2587
        • Brożek J.L.
        • Bousquet J.
        • Agache I.
        • et al.
        Allergic rhinitis and its impact on asthma (ARIA) guidelines—2016 revision.
        J Allergy Clin Immunol. 2017; 140: 950-958
        • Agnese C.
        • Martone A.M.
        • Andrea P.
        • et al.
        Anticholinergic drugs and negative outcomes in the older population: from biological plausibility to clinical evidence.
        Aging Clin Exp Res. 2016; 28: 25-35
        • Gray S.L.
        • Anderson M.L.
        • Dublin S.
        • et al.
        Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study.
        JAMA Intern Med. 2015; 175: 401-407
        • Ousler G.W.
        • Wilcox K.A.
        • Gupta G.
        • et al.
        An evaluation of the ocular drying effects of 2 systemic antihistamines: loratadine and cetirizine hydrochloride.
        Ann Allergy Asthma Immunol. 2004; 93: 460-464
        • Vacchiano C.
        • Moore J.
        • Rice G.M.
        • et al.
        Fexofenadine effects on cognitive performance in aviators at ground level and simulated altitude.
        Aviat Space Environ Med. 2008; 79: 754-760
        • Simons F.E.R.
        Advances in H1-antihistamines.
        N Engl J Med. 2004; 351: 2203-2217
        • De Weck A.L.
        • Derer T.
        • Bähre M.
        Investigation of the anti-allergic activity of azelastine on the immediate and late-phase reactions to allergens and histamine using telethermography.
        Clin Exp Allergy. 2000; 30: 283-287
        • Kaliner M.A.
        • Oppenheimer J.
        • Farrar J.R.
        Comprehensive review of olopatadine: the molecule and its clinical entities.
        Allergy Asthma Proc. 2010; 31: 112-119
        • Van Cauwenberge P.
        • Bachert C.
        • Passalacqua G.
        • et al.
        Consensus statement on the treatment of allergic rhinitis.
        Allergy. 2000; 55: 116-134
        • Yáñez A.
        • Rodrigo G.J.
        Intranasal corticosteroids versus topical H1 receptor antagonists for the treatment of allergic rhinitis: a systematic review with meta-analysis.
        Ann Allergy Asthma Immunol. 2002; 89: 479-484
        • Kaliner M.A.
        • Storms W.
        • Tilles S.
        • et al.
        Comparison of olopatadine 0.6% nasal spray versus fluticasone propionate 50 [micro]g in the treatment of seasonal allergic rhinitis.
        Allergy Asthma Proc. 2009; 30: 255-262
        • Ratner P.H.
        • Hampel F.
        • Van Bavel J.
        • et al.
        Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis.
        Ann Allergy Asthma Immunol. 2008; 100: 74-81
        • Tietze K.I.N.
        Cromolyn sodium has limited use in self-management of allergic rhinitis.
        Pharm Today. 2017; 23: 16
        • Milgrom H.
        • Biondi R.
        • Georgitis J.W.
        • et al.
        Comparison of ipratropium bromide 0.03% with beclomethasone dipropionate in the treatment of perennial rhinitis in children.
        Ann Allergy Asthma Immunol. 1999; 83: 105-111
        • Nayak A.
        • Langdon R.B.
        Montelukast in the treatment of allergic rhinitis: an evidence-based review.
        Drugs. 2007; 67: 887-901
        • Wilson A.M.
        • O’Byrne P.M.
        • Parameswaran K.
        Leukotriene receptor antagonists for allergic rhinitis: a systematic review and meta-analysis.
        Am J Med. 2004; 116: 338-344
        • Grainger J.
        • Drake-Lee A.
        Montelukast in allergic rhinitis: a systematic review and meta-analysis.
        Clin Otolaryngol. 2006; 31: 360-367
        • Pullerits T.
        • Praks L.
        • Ristioja V.
        • et al.
        Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis.
        J Allergy Clin Immunol. 2002; 109: 949-955
        • Lagos J.A.
        • Marshall G.D.
        Montelukast in the management of allergic rhinitis.
        Ther Clin Risk Manag. 2007; 3: 327-332
        • Meltzer E.O.
        • Malmstrom K.
        • Lu S.
        • et al.
        Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial.
        J Allergy Clin Immunol. 2000; 105: 917-922
        • Cingi C.
        • Gunhan K.
        • Gage-White L.
        • et al.
        Efficacy of leukotriene antagonists as concomitant therapy in allergic rhinitis.
        Laryngoscope. 2010; 120: 1718-1723
        • Haarman M.G.
        • van Hunsel F.
        • de Vries T.W.
        Adverse drug reactions of montelukast in children and adults.
        Pharmacol Res Perspect. 2017; 5: e00341
        • Department of Health and Human Services
        Final Monograph for OTC Nasal Decongestant Drug Products; Final Rule.
        Fed Regist. 1994; 59 (FR Doc No: 94-20456)
        • Baroody F.M.
        • Brown D.
        • Gavanescu L.
        • et al.
        Oxymetazoline adds to the effectiveness of fluticasone furoate in the treatment of perennial allergic rhinitis.
        J Allergy Clin Immunol. 2011; 127: 927-934